The Doctor’s Dose

Palantir CEO Alex Karp stock sale: price impact and a day-trading playbook A new Palantir CEO, Alex Karp, stock sale disclosed via Form 4 shows 409,072 shares sold last week (automatic transactions tied to tax withholding on vested RSUs) at ~$142.46–$157.56. PLTR...

NIO Stock Soars on ES8 Launch (Aug 2025) A cheaper ES8 with Battery‑as‑a‑Service, the new L90, and improving deliveries have investors re‑rating NIO. Here’s what changed—and how to trade it. What’s New · Why It Matters · Delivery Momentum · Rivals & Price War ·...

US stablecoin rules deposit outflows — the fight over a “yield” loophole Bank trade groups want Congress to amend the new GENIUS Act because they say a loophole lets exchanges indirectly pay interest on third-party stablecoins. They argue that this could trigger US...

xAI lawsuit against Apple and OpenAI over ChatGPT–iPhone integration Elon Musk’s xAI filed a federal antitrust complaint in Texas alleging that Apple’s integration of ChatGPT into iPhones and App Store promotion practices unfairly disadvantage rivals like Grok. Apple...

Nvidia Jetson AGX Thor Robot Brain: A Fresh Catalyst for NVDA Nvidia’s new Nvidia Jetson AGX Thor robot brain platform—built on Blackwell—arrives with developer kits at $3,499 and production Jetson T5000 modules for scaled deployments. What launched—and why it matters...

Tesla Stock Soars on Rate‑Cut Hopes (Aug 2025) Powell’s Jackson Hole remarks pushed rate‑cut odds higher and lifted risk assets—TSLA included. Meanwhile, Tesla’s new Cybertruck Luxe Package grabbed headlines but remains a sideshow to the rates story. Overview · Rates...

Week Ahead: Nvidia earnings and PCE inflation gauge (Aug 25–29, 2025) In the wake of Fed Chair Jerome Powell’s Jackson Hole remarks, markets face a packed slate of economic data and high‑impact earnings—headlined by the Fed’s preferred inflation measure and Nvidia’s...

Japanese Stocks Soar Despite Tariffs and Turmoil (Aug 2025) EWJ and key indices in Tokyo keep climbing even as the U.S. locks in 15% reciprocal tariffs and Japan’s ruling coalition loses its upper‑house majority. Here’s what’s driving the rally—and how to trade it....

The MTRI Impulsivity Dimension: Fast vs. Reflective Decisions in Trading Our background in behavioral finance has had Traderinsight.com focused on the psychological development of traders for three decades.  It's only a recent evolution that has media outlets like...

Target CEO Change Overshadows Earnings: What Day Traders Should Watch Target posted a slight Q2 beat, but price action says the leadership shift is the real catalyst. Here’s how to trade the reaction—because in the short term, Target CEO change overshadows earnings....

Meme Stock Pump-and-Dump Scams: A Day Trader’s Survival Guide In July, a fresh wave of meme-stock “ramps” rocketed thinly traded microcaps before collapsing just as fast—leaving billions in paper wealth erased and a trail of retail accounts blown up. Here’s what...

Advance Auto Parts (AAP) After Earnings: A Deeper Dive and Day-Trading Playbook Advance Auto Parts posted an EPS beat but guided 2025 lower as interest expense rises following a $1.95B notes offering. The stock’s third straight double-digit post-earnings move makes...

Oracle’s AI Rally Pauses: A Deeper Dive with Day-Trading Setups Oracle (ORCL) slipped more than 4% to ~238 after a torrid June–July run that peaked at 260.87. Price is now decisively below the 21-day moving average while still hovering a few percent above the 50-day,...

The MTRI Neuroticism Dimension in Trading: How Emotional Reactivity Shapes Decisions In our last article, we looked at how the Manz Trader Readiness Inventory can be used as a tool for traders to understand how their psychology affects performance.  Today, we will...

Merck Keytruda Medicare Delay: What It Means for Day Traders The recent tweak to Medicare’s drug price negotiation program has given Merck (MRK) a brief lifeline. While long-term investors are debating whether the change truly softens the looming Keytruda patent...

A Tweak to Medicare is Good for Merck. But Can It Revive the Stock? Merck & Co. has found a small reprieve in Washington, but investors remain skeptical that it will meaningfully alter the company’s trajectory. A new tweak to Medicare’s drug price negotiation...

September Fed Rate Cut: Why Day Traders Should Prepare for a Hawkish Surprise Fed expectations vs. market reality The S&P 500, currently hovering above 6400, has rallied on expectations of a September Fed rate cut. Fed funds futures are pricing an 85% chance of a...

The Manz Trader Readiness Inventory: Measuring Psychological Fitness for Day Trading Success in day trading is about much more than mastering technical setups or memorizing chart patterns. While strategy and execution are essential, they’re only part of the equation....

Intel Government Stake Talks and Day Trading Implications The Trump administration is reportedly considering a 10% equity stake in Intel (INTC), which would convert billions in CHIPS Act funding into ownership. The proposal underscores Washington’s deepening...